237 related articles for article (PubMed ID: 32386122)
1. Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
Yoshino H; Enokida H; Osako Y; Nohata N; Yonemori M; Sugita S; Kuroshima K; Tsuruda M; Tatarano S; Nakagawa M
Mol Oncol; 2020 Sep; 14(9):2190-2202. PubMed ID: 32386122
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
[TBL] [Abstract][Full Text] [Related]
3. PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.
Yoshino H; Nohata N; Miyamoto K; Yonemori M; Sakaguchi T; Sugita S; Itesako T; Kofuji S; Nakagawa M; Dahiya R; Enokida H
Cancer Res; 2017 Nov; 77(22):6321-6329. PubMed ID: 28951458
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells.
Zhang X; Taoka R; Liu D; Matsuoka Y; Tohi Y; Kakehi Y; Sugimoto M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921102
[TBL] [Abstract][Full Text] [Related]
6. No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine.
Camargo EA; da Silva GN; Gobette CP; Marcondes JP; Salvadori DM
Asian Pac J Cancer Prev; 2013; 14(10):5941-8. PubMed ID: 24289605
[TBL] [Abstract][Full Text] [Related]
7. Anti-Cancer Effects and Tumor Marker Role of Glutathione
Jou YC; Wang SC; Dia YC; Wang ST; Yu MH; Yang HY; Chen LC; Shen CH; Liu YW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802702
[TBL] [Abstract][Full Text] [Related]
8. Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
Yoshino H; Yokoyama S; Tamai M; Okamura S; Iizasa S; Sakaguchi T; Osako Y; Inoguchi S; Matsushita R; Yamada Y; Nakagawa M; Tatarano S; Tanimoto A; Enokida H
FEBS Open Bio; 2023 Jun; 13(6):1056-1066. PubMed ID: 37079001
[TBL] [Abstract][Full Text] [Related]
9. Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells.
Hodzic J; Giovannetti E; Diosdado B; Adema AD; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1214-22. PubMed ID: 22132977
[TBL] [Abstract][Full Text] [Related]
10. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
[TBL] [Abstract][Full Text] [Related]
11. Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.
Dong JK; Lei HM; Liang Q; Tang YB; Zhou Y; Wang Y; Zhang S; Li WB; Tong Y; Zhuang G; Zhang L; Chen HZ; Zhu L; Shen Y
Theranostics; 2018; 8(7):1808-1823. PubMed ID: 29556358
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
13. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059
[TBL] [Abstract][Full Text] [Related]
14. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation.
Ou Y; Wang SJ; Jiang L; Zheng B; Gu W
J Biol Chem; 2015 Jan; 290(1):457-66. PubMed ID: 25404730
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.
da Silva GN; de Castro Marcondes JP; de Camargo EA; da Silva Passos Júnior GA; Sakamoto-Hojo ET; Salvadori DM
Exp Biol Med (Maywood); 2010 Jul; 235(7):814-24. PubMed ID: 20558835
[TBL] [Abstract][Full Text] [Related]
16. MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells.
da Silva GN; de Camargo EA; Sávio AL; Salvadori DM
Mol Biol Rep; 2014 Jul; 41(7):4613-21. PubMed ID: 24652204
[TBL] [Abstract][Full Text] [Related]
17. Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer.
Itoyama R; Yasuda-Yoshihara N; Kitamura F; Yasuda T; Bu L; Yonemura A; Uchihara T; Arima K; Hu X; Jun Z; Okamoto Y; Akiyama T; Yamashita K; Nakao Y; Yusa T; Kitano Y; Higashi T; Miyata T; Imai K; Hayashi H; Yamashita YI; Mikawa T; Kondoh H; Baba H; Ishimoto T
Cancer Lett; 2021 Dec; 523():29-42. PubMed ID: 34508795
[TBL] [Abstract][Full Text] [Related]
18. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.
Zhang Y; Wan X; Yang X; Liu X; Huang Q; Zhou L; Zhang S; Liu S; Xiong Q; Wei M; Qiu L; Zhang B; Han J
J Biol Chem; 2023 Sep; 299(9):105177. PubMed ID: 37611825
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
20. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
